Technical Analysis for QNRX - Quoin Pharmaceuticals, Ltd.

Grade Last Price % Change Price Change
F 0.65 3.82% 0.02
QNRX closed down 1.17 percent on Wednesday, November 20, 2024, on 2 percent of normal volume. It ran into resistance at its 50 day moving average. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Up

Date Alert Name Type % Chg
50 DMA Resistance Bearish 3.82%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 3.82%
Inside Day Range Contraction 3.82%
Wide Bands Range Expansion 3.82%
Oversold Stochastic Weakness 3.82%
50 DMA Resistance Bearish 2.61%
Outside Day Range Expansion 2.61%
Wide Bands Range Expansion 2.61%
Oversold Stochastic Weakness 2.61%
50 DMA Resistance Bearish 8.25%

   Recent Intraday Alerts

Alert Time
Up 3% about 1 hour ago
60 Minute Opening Range Breakout about 1 hour ago
Rose Above 50 DMA about 1 hour ago
Rose Above 10 DMA about 1 hour ago
50 DMA Resistance about 3 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Founded in 2018 as Quoin Pharmaceuticals Inc. by Michael Myers Ph.D. and Denise Carter, Quoin is an emerging specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. We are committed to addressing unmet medical needs for patients, their families, communities and care teams. Quoin’s innovative pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa and others.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Pharmaceutical Therapeutic Products Genodermatoses Epidermolysis Bullosa Netherton Syndrome Rare And Orphan Diseases

Is QNRX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 6.18
52 Week Low 0.4772
Average Volume 2,813,220
200-Day Moving Average 0.90
50-Day Moving Average 0.63
20-Day Moving Average 0.71
10-Day Moving Average 0.63
Average True Range 0.09
RSI (14) 45.05
ADX 45.3
+DI 31.36
-DI 15.66
Chandelier Exit (Long, 3 ATRs) 0.70
Chandelier Exit (Short, 3 ATRs) 0.83
Upper Bollinger Bands 0.89
Lower Bollinger Band 0.53
Percent B (%b) 0.26
BandWidth 50.99
MACD Line -0.02
MACD Signal Line 0.00
MACD Histogram -0.0165
Fundamentals Value
Market Cap 617.6 Thousand
Num Shares 987 Thousand
EPS 1.38
Price-to-Earnings (P/E) Ratio 0.45
Price-to-Sales 0.00
Price-to-Book 0.45
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.70
Resistance 3 (R3) 0.71 0.68 0.69
Resistance 2 (R2) 0.68 0.66 0.68 0.68
Resistance 1 (R1) 0.65 0.65 0.64 0.65 0.68
Pivot Point 0.63 0.63 0.63 0.63 0.63
Support 1 (S1) 0.60 0.61 0.59 0.60 0.57
Support 2 (S2) 0.58 0.60 0.58 0.57
Support 3 (S3) 0.55 0.58 0.56
Support 4 (S4) 0.55